Latest News for: mhlw

Edit

Quoin Pharmaceuticals Announces Japan's MHLW Grants Orphan Drug Designation for QRX003 in Netherton Syndrome

Nasdaq Globe Newswire 04 Jun 2026
-Designation provides regulatory and development incentives in Japan, including up to 10 years of market exclusivity upon approval- ... .
Edit

Quoin Pharmaceuticals Announces Japan's MHLW Grants Orphan Drug Designation for QRX003 in

Caledonian Record 04 Jun 2026
-Designation provides regulatory and development incentives in Japan, including up to 10 years of market exclusivity upon approval- ....
Edit

Quoin Pharmaceuticals Announces Japan's MHLW Grants Orphan Drug Designation for QRX003 in Netherton Syndrome (Form 8-K) (Quoin Pharmaceuticals Ltd)

Public Technologies 04 Jun 2026
Quoin Pharmaceuticals Announces Japan's MHLW Grants Orphan Drug Designation for QRX003 in Netherton Syndrome ... The MHLW grants Orphan Drug Designation to medicines intended to treat rare diseases that ...
  • 1

Article Search

tools
×
×
×
×